NEW YORK, Oct. 24, 2016 /PRNewswire/ -- CPhI North
America, the next iteration of the iconic CPhI brand, will be the
epicenter of pharmaceutical innovation, emerging trends, insights,
and community-building connections in North America. Those seeking powerful
partnerships will come together to illuminate the path towards high
growth in this ever-evolving industry. The inaugural event will
take place on May 16–18, 2017, at the Pennsylvania Convention Center in Philadelphia, PA, USA adjacent to the
33rd edition of
InformEx, the home of fine and specialty chemicals.
Registration is now open at www.cphinorthamerica.com.
Pharmaceutical executives along with R&D, compliance,
regulatory, manufacturing, QA/QC, supply chain, packaging, and
procurement professionals will gather to build connections, to
capitalize on emerging trends, further innovation, and tackle
industry challenges.
The launch of CPhI North America has been strategically timed to
take advantage of strong industry growth and innovation while
addressing the ever-increasing challenges to the future prosperity
of the industry. North American pharmaceutical revenue growth is
strong, the United States saw an
8.5% growth in 2015. As leaders in pharmaceutical innovation, North
American organizations develop a staggering 36% of the world's new
molecular entities (NME). With incredible advancements in the
understanding of how to treat a wide range of disease states, the
pharmaceutical industry now has greater opportunities than ever
before.
However, the industry is facing staggering price control
pressures, research and development (R&D) inefficiencies, a
need to efficiently manufacture new types of drugs, and mounting
regulatory complexity. Industry changes, challenges, and
opportunities call for a new event that can help the industry move
forward in new ways.
"CPhI North America will provide an unrivalled opportunity to
become a key stakeholder in the largest pharmaceutical market,"
said Robyn Duda, CPhI North America
Portfolio Director. "With the projected growth of the pharma
industry in this region and the real challenges the industry is
facing, there isn't a better time to bring such an established
brand to North American pharma market in 2017."
As if the power of CPhI was not enough, CPhI North America will
be held adjacent to InformEx, the world's leading show for the
high-value specialty chemicals marketplace. CPhI North America
attendees will benefit from the tremendous specialty chemical
expertise InformEx assembles, which is essential to the success of
pharmaceutical product development.
Supporting Innovation within the Complete Pharmaceutical
Lifecycle
CPhI North America has been expressly designed to serve the full
pharmaceutical value chain. The exhibit floor will be zoned to
facilitate a more intimate and efficient experience allowing
attendees to customize their experiences. Zones include:
- iCSE: The Drug Development zone will highlight
world-class CROs and other organizations serving drug
developers.
- CPhI: The Manufacturing Ingredients zone will consist of
active product ingredients (API) and excipient leaders.
- FDF: The Finished Drug Products zone will feature
leading small and large molecule CDMO/CMOs.
- InnoPack: The Packaging zone will showcase packaging
innovation.
In addition to the zoned show floor populated with leading
industry organizations and solutions, CPhI North America will offer
attendees unique opportunities to stay ahead of trends and connect
with industry leaders:
A Focus on Innovation: See the latest technologies,
products, and approaches at one of the Insight Briefings or at the
Innovation & Product Gallery. Join industry professionals as
they network and discuss innovations and challenges of common
interest and mutual benefit. Leading organizations who have already
joined the event include:
- Abbvie
- Acebright
- AMRI
- Ashland
- Austin Chemical
- BASF
- Biospectra
- Capsugel
- Catalent
- Chemo
- Colorcon
- DFE Pharma
- FMC Corporation
- Fresenius Kabi
- Millipore Sigma-Merck
- Patheon
- Pfizer
- Softigel Procaps
Network with New and Existing Partners: Meet key players
and potential partners at events that bring the industry at large
together, or one of the smaller, targeted events held for specific
functions or areas of interest.
One to One Matchmaking: CPhI North America will be
unveiling a customized matchmaking solution for buyers and sellers
to meet and do business better than ever before.
World-Class Educational Programming: CPhI North America
has forged strategic partnerships with the American Chemical
Society (ACS), the largest scientific association in the world, and
CBI, the industry leader in actionable life sciences content and
analysis. Through these partnerships, CPhI North America has
created rich programming that addresses the full spectrum of the
pharmaceutical value chain.
The educational programming includes a technical conference
covering the most pressing topics within drug development,
formulation, manufacturing, and outsourcing. The program, Connect
CPhI, will also include a Regulatory Town Hall and keynote sessions
with the FDA and leading global regulators. The programming will
extend onto the show floor where trends and insights will be shared
by industry leaders.
"ACS is excited to partner with the CPhI North America and
InformEx events in order to provide outstanding educational content
and new programming to support drug development and chemical supply
chains. Our deep experience with the chemical enterprise, coupled
with our global awareness of the scientific and regulatory
landscape will allow us to provide unique programs and services to
the pharmaceutical and specialty chemical communities," said
Susan Pastore, Senior Advisor at the
American Chemical Society.
Utilizing the strength of the CPhI brand and its network of
global events, CPhI North America will assemble leading
pharmaceutical professionals, provide a marketplace that supports
custom experiences for each attendee's needs, enable key business
leaders to develop and foster dynamic business relationships, and
provide a forum for solving some of the pharmaceutical industry's
most pressing challenges.
CPhI North America will be held May 16–18, 2017, at the
Pennsylvania Convention Center.
Register today to participate in the hub of North American
pharmaceutical innovation. Registration is now open at
www.cphinorthamerica.com
Download Word Version of Press Release
About CPhI
CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI
brings together more than 100,000 pharmaceutical professionals each
year to network, identify business opportunities and expand the
global market. CPhI hosts events across Europe, Asia
and, now, North America and
co-locates with ICSE for contract services, P-MEC for machinery,
equipment & technology, InnoPack for pharmaceutical packaging
and BioPh for biopharma. CPhI provides an online buyer &
supplier directory at CPhI-Online.com.
For more information visit: www.cphi.com.
About UBM Americas
UBM Americas, a part of UBM plc, delivers events and marketing
services in the fashion technology, licensing, advanced
manufacturing, automotive and powersports, healthcare, veterinary
and pharmaceutical industries, among others. Through a range of
aligned interactive environments, both physical and digital, UBM
Americas increases business effectiveness for customers and
audiences through meaningful experiences, knowledge and
connections.
The division also includes UBM Brazil's market leading events in
construction, cargo transportation, logistics & international
trade, and agricultural production; and UBM Mexico's, construction,
advanced manufacturing and hospitality services shows. For more
information, visit: www.ubmamericas.com
Photo - http://photos.prnewswire.com/prnh/20161021/431407
Logo - http://photos.prnewswire.com/prnh/20161021/431473LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/secure-your-place-in-the-hub-of-pharmaceutical-innovation-in-may-2017-300349652.html
SOURCE CPhI